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Background: In previous studies, the Irritable
Bowel Syndrome Quality of Life (IBS-QOL) instru-
ment has been determined to have good measurement
properties for general irritable bowel syndrome (IBS)
and the diarrheal IBS (IBS-d) subtype in clinical trials.
Objective: This article aims to extend the true-score
analyses that have been previously conducted to
evaluate the IBS-QOL in IBS-d patients.
Methods: Item response theory analysis was con-
ducted by ﬁtting models to responses from 753
patients with severe IBS-d from a recent clinical trial.
Three item response theory models, the constrained
graded response model (CGRM), the unconstrained
GRM (UGRM), and the testlet response model
(TRM), were ﬁt to the 34 items of the IBS-QOL
questionnaire. Subsequently, differential item func-
tioning (DIF) for patient sex was assessed by ﬁtting
nested models by applying likelihood ratio tests.
Model latent trait estimates were then compared with
the IBS-QOL score and the IBS Symptom Severity
Score.
Results: Model ﬁts improved with complexity, with
the TRM model ﬁtting best compared with the
CGRM and UGRM. The DIF evaluation for patient
sex ﬂagged 17 items for the CGRM and 9 items for
the UGRM; however, these items were not found to
have much effect on the overall estimation of the
latent trait. Differential testlet functioning was not
indicated, and no items exhibited potential DIF underAccepted for publication April 9, 2014.
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May 2014the TRM because likelihood ratio tests were not
statistically signiﬁcant. Comparison of latent trait
estimates to the IBS Symptom Severity Score and
IBS-QOL questionnaire revealed high Spearman cor-
relations (0.47 and Z0.99, respectively).
Conclusion: Previous true-score approach results
were supported by the IBS-QOL item-level analysis.
Further, the IBS-QOL total score was found to be a
valid measure of perceived quality of life for IBS-d
patients when compared with more sophisticated
model-based estimates of perceived quality of life.
ClinicalTrials.gov identiﬁer: NCT01130272. (Clin
Ther. 2014;36:663–679) & 2014 The Authors. Pub-
lished by Elsevier HS Journals, Inc. All rights reserved.
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syndrome, item response theory, patient-reported out-
comes, psychometrics, quality of life.INTRODUCTION
Irritable bowel syndrome (IBS) is a debilitating func-
tional gastrointestinal disorder that affects an esti-
mated 10% to 15% of people in Western cultures.1
Irritable bowel syndrome is characterized by recurrent
abdominal discomfort and pain associated with
altered bowel habits.2 Current medical guidelines (ie,
Rome III criteria) determine IBS subtypes by stool
consistency patterns, such as diarrheal IBS (IBS-d), IBS
with constipation, or IBS with both constipation andScan the QR Code with your phone to obtain
FREE ACCESS to the articles featured in the
Clinical Therapeutics topical updates or text
GS2C65 to 64842. To scan QR Codes your
phone must have a QR Code reader installed.
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Clinical Therapeuticsdiarrhea.3 In addition, IBS can negatively affect an
individual’s perceived quality of life (QOL), and
research indicates that patients with IBS incur
signiﬁcant direct and indirect costs associated with
the condition. Current tolerable and effective
pharmacologic treatments for IBS are limited,
with current treatment options that include antispa-
smodics, antidepressants, antidiarrheal agents, and
alosetron.4
Recently, a large Phase II clinical trial of eluxado-
line, a mixed μ-opioid agonist and δ-opioid antagonist
in patients with IBS-d was reported.5 One of the
exploratory objectives of the trial was to evaluate
the psychometric properties of perceived QOL
instruments administered to the patients enrolled in
the study. Previous psychometric validation has
focused on a true-score theory approach (ie, classic
test theory [CTT]) to the IBS-QOL with the original
CTT validation work performed on an overall, non-
subtyped patient set.6–8 The IBS-QOL questionnaire is
a 34-item instrument designed from a needs-based
conceptual paradigm, and scoring is composed of a
total score and 8 subscale scores that have been
validated for a general IBS patient population. Recent
research on the true-score properties of the IBS-QOL
in IBS-d–speciﬁc patients has yielded information
about the total score and not the substructure of the
IBS-QOL is the best measurement model for IBS-d
patients.9 Speciﬁcally, Andrae et al9 concluded that
the IBS-QOL may have individual items that do not
pertain directly to IBS-d patients but that the ques-
tionnaire is likely measuring a unidimensional con-
struct. Further, their analyses did not directly support
the original substructure as determined by the original
research on a set of patients with IBS with both
constipation and diarrhea. Because the IBS-QOL
questionnaire has been widely studied via CTT meth-
ods, we intended to further explore these recent
developments with the use of item-centered methods.
This article uses several item response theory (IRT)
approaches to extend the previous psychometric as-
sessments of the IBS-QOL questionnaire in an attempt
to determine whether item-level data elucidate aspects
of measurement of perceived QOL beyond previously
validated scoring methods.
At the heart of CTT approaches to psychometrics is
the idea that the latent construct of interest is best
measured by a single score from the instrument (eg,
the sum of scored items or, as in the IBS-QOL664questionnaire, a standardized total score). Such an
approach typically assumes that all items contribute
equally to measuring the construct. The IRT methods,
in contrast, focus evaluation on the individual items
themselves by ﬁtting model parameters that relate
items to the latent trait under study. The focus on
individual items in the IRT methods is ideal for
assessing the IBS-QOL questionnaire in IBS-d patients
because there are previous indications that certain
items do not perform well in using the IBS-QOL
questionnaire to assess perceived QOL for IBS-d
patients.
The current paper aims to use IRT modeling to
complement and extend the results of the classic
psychometric assessments described by Andrae
et al.9 Speciﬁcally, different graded response models
(GRMs)10 were ﬁt to the items of the IBS-QOL
questionnaire. Although the CTT methods focus on
the characteristics of the instrument as a whole (ie,
that the sum or total score from an instrument serves
as a best estimate of some latent trait of interest),
modern methods use individual item responses as
means of assessing latent traits. The idea is that
individual items each measure some aspect of a latent
trait that is not directly observable. Therefore, by
directly modeling the contributions of the items to the
measurement of this latent trait, one can gain a
richness of measurement not gotten by summed
scores. In turn, then, by modeling IBS-QOL question-
naire items as opposed to overall scores, it is hoped
that better precision can be gained with regard to
characterizing and measuring perceived QOL—the
latent trait in the current case—for IBS-d patients.METHODS
All analyses were applied to a sample of 753 patients
who completed a baseline administration of the IBS-
QOL questionnaire while participating in a Phase II
study of eluxadoline for the treatment of IBS-d.
Patients were recruited between May 2010 and April
2011 from 292 centers in the United States. Further
details of study conduct are reported elsewhere.5
Patients were diagnosed as having IBS-d according
to Rome III criteria. The study was completed in
compliance with good clinical practice guidelines and
the Declaration of Helsinki. Analyses were conducted
using R version 3.0.2 (R Foundation for Statistical
Computing, Vienna, Austria).Volume 36 Number 5
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As stated above, previous work on the IBS-QOL
has centered on the CTT methods. In a true-score
approach, some measure of overall instrument score is
the fungible unit by which an instrument measures the
latent construct under study. The IRT methods shift
the fungible unit to individual item responses. These
responses are used jointly to estimate the latent
construct. In the current case, the latent construct is
IBS-d–related QOL, represented by the Greek letter θ,
and because items are rated by patients on 5-point
Likert-type responses, analyses were performed using
models appropriate for graded responses.10 Two types
of GRMs were ﬁt to the data.
The ﬁrst model ﬁt was the constrained GRM
(CGRM). In this model, only item intercepts are
estimated, not slopes. For patient i and item j, the
probability of response uij is greater than or equal to a
response level k, as given in model 1:
PrðujkZkjθÞ¼
exp ðαjkþθiÞ
1þexp ðαjkþθiÞ
ð1Þ
where αjk represent the thresholds between ordinal
responses (ie, the location parameters), and θ is the
latent construct measured by the items. In model 1 the
linear predictor for each item is constrained to be
equal to 1 and is constant across items. Probabilities
of actual responses are then calculated by the differ-
ences between adjacent categories by taking the differ-
ences between response categories:
Pr ðuij ¼ kjθÞ ¼ Prðuij Z kjθÞ  Prðuij Z k þ 1jθÞ
where Pr(uij Z 1)  1.11 Another way of conceptua-
lizing the CGRM is that each item is given equal
weight in measuring θ and that the equal weighting is
standardized to a value of 1, indicating that a patient’s
perceived QOL is, ostensibly, measured only by the
item intercepts (ie, the location of the items on the
latent continuum). The CGRM ﬁt in the current article
is similar in parameterization of the linear predictor to
the partial credit model, a member of the Rasch family
of IRT models.12 Because the Rasch family of models
deﬁne response probabilities not in terms of
differences between adjacent categories but rather in
terms of the proportion of total response probability
for each item (ie, the so-called divide by total mod-
els),13 the CGRM was ﬁt here for consistency of the
statistical paradigm.May 2014Although the CGRM is a parsimonious means of
relating item responses to θ, such an approach may not
be reasonable for all item sets. Therefore, an uncon-
strained GRM (UGRM) was also ﬁt to see whether the
CGRM assumptions were reasonable for the IBS-QOL
data as in model 2:
PrðuijZkjθÞ¼
exp ðαjkþβjθiÞ
1þexp ðαjkþβjθiÞ
ð2Þ
which allows the item slopes βj to vary across the j items
of a given scale and is also estimated so that it can be a
value different than 1. The slope parameters are inter-
preted as higher value that represented higher discrim-
ination between levels of θ. Comparing model 2 to
model 1, one can see many similarities. In fact, the only
difference is that the βj values in model 1 are all set to
equal rather than estimated for each item as in model 2.
Likewise, the intercept terms αjk in both models 1 and 2
can be thought of as the location of a given response k
to a given item j on the latent variable scale. In the case
of graded responses, higher slope values mean that
individual response probabilities are more well deﬁned
and distinct from one another across responses than for
items with lower slope values and item intercepts. Thus,
UGRMs with slopes that span a large range indicate that
discrimination can be had over a wide range of latent
variable values.
Because it is hypothesized that the IBS-QOL ques-
tionnaire items will not equally relate to θ for an IBS-d
patient set because the items were generated for a
patient population with nonsubtyped IBS, it is ex-
pected that the UGRM ﬁt the data better than the
CGRM. This hypothesis is supported by the previous
factor analyses of the IBS-QOL questionnaire because
the factor loadings in the single-factor model were
found to be unequal.9 Determination of relative model
ﬁt is assessed by a signiﬁcant likelihood ratio (LR) χ2
(ie, by comparing 2 times the difference in the log
likelihood of the models to a χ2 distribution with
degrees of freedom equal to the difference in the
number of model parameters).
Testlet Response Model
Like many other IRT models, GRMs have 2 core
assumptions: (1) the unidimensionality assumption
(the latent construct being measured is homogeneous)
and (2) the local independence assumption (that the
individual items are independent from one another
when accounting for θ). One of the criticisms of IRT665
Table I. Items grouped into testlets for the
testlet response model.
Testlet
No. Items
I 11. I have to watch the amount of food I
eat because of my bowel problems.
23. I have to watch the kind of food I
eat because of my bowel problems.
28. I feel frustrated that I cannot eat
when I want because of my bowel
problems.
II 12. Because of my bowel problems,
sexual activity is difﬁcult for me.
20. My bowel problems reduce my
sexual desire.
Clinical Therapeuticsmodels that allow estimation of different slopes is that
such different discrimination parameters across items
could suggest a lack of unidimensionality of the latent
construct being measured, thereby violating assump-
tion 1.14 Questions can also be raised as to whether
so-called local dependencies negatively inﬂuence
model assumptions because differential slopes could
suggest interrelationships among items, potentially
violating assumption 2.14 Because previous CTT
approaches to psychometric analyses of the IBS-
QOL questionnaire revealed indications of minor
deviations from the single-factor model for the items,
indicating that the unidimensionality and local inde-
pendence assumptions for the GRM may not hold, an
alternative conceptualization was warranted.9 Testlet
response theory (TRT) approaches the psychometric
assessment of an instrument using groups of items, or
testlets, as the fungible unit of measurement of latent
traits.14–16 Comparatively, the fungible units of meas-
urement in true-score theory and IRT are, respectively,
the total score from the instrument and the items.
Although TRT is usually applied as an a priori test
construction method (eg, several comprehension ques-
tions about a single reading passage), in the current
case we are attempting to see whether item content
similarities may lead to the deviations in the single-
factor structure and thus manifest as potential viola-
tions of the conditional independence of the GRM. By
ﬁtting a testlet response model (TRM) one can
perform statistical evaluation of the effect due to
potential departures from the GRM assumptions
because item local dependence patterns can be built
into the model. To account for potential local depend-
encies between sets of items, random effects will be ﬁt
in addition to the GRM in models 1 and 2. Speciﬁ-
cally, we deﬁne the TRM as follows:
PrðuijZkjθÞ ¼
exp ðαjkþβjθiþζitðjÞÞ
1þexp ðαjkþβjθiþζitðjÞÞ
ð3Þ
where ζit(j)  Normal(0,var(ζit(j))) represents the crossed
random effects of testlet t containing speciﬁc items j.
Model 3 is a special case of the bifactor model,17 with
speciﬁc subsets of items loading on the nongeneral
factors (ie, testlets). For identiﬁcation of the model, the
slopes of each item on each testlet are constrained to be
equal to that same item’s slope on the general factor.
This allows the variance within a testlet, var(ζit(j)), to be
estimated across these slopes, thereby accounting for
any dependencies among items within a testlet. By666comparison, the traditional bifactor model constrains
variances of all factors to be 1, allowing estimation of
item slopes to vary between general and speciﬁc factors.
Therefore, the TRM model, to the extent the model is
properly constructed, statistically controls for local
dependencies by allowing estimation of variances
across items within testlets,
In the current case, 2 testlets were determined by
content review. Table I displays the items that were
grouped into 2 testlets, roughly relating to “food” and
“sexual” items. Although other testlet conﬁgurations
may result in better identiﬁcation of fungible units
within the IBS-QOL questionnaire, further research
beyond the scope of the current article, including
qualitative assessment by patients and experts, is
warranted to adequately determine the appropriate
testlets.Differential Functioning
Because previous investigations of IBS-d treatments
have almost exclusively included only women, differ-
ential item functioning (DIF) due to patient sex was
assessed by comparing the ﬁt of models 1 and 2 on the
IBS-QOL questionnaire with the following models.
PrðuijZkjθÞ¼
exp ðαjkþθiþγjxþδjθixÞ
1þexp ðαjkþθiþγjxxþδjθxÞ
ð4Þ
PrðuijZkjθÞ¼
exp ðαjkþβjθiþγjxþδjθixÞ
1þexp ðαjkþβjθiþγjxxþδjθixÞ
ð5ÞVolume 36 Number 5
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QOL-level interaction effects are sequentially added to
the model. Iterative model ﬁtting and evaluation used
the “multipleGroup” function within the MIRT pack-
age, version 1.1 (Vector Psychometric Group, Chapel
Hill, North Carolina). Models 4 and 5 represent the
DIF assessments for the CGRM and UGRM from
above, respectively. The LR tests between models 1 and 4
and models 2 and 5 were evaluated as indications of
overall presence of DIF for a given item as tested by a LR
χ2 test with 2 df. In an attempt to identify speciﬁc items
that may exhibit DIF, we compared each model to all
subset models in which single items were excluded in
turn, and the 33 remaining items were ﬁt to the GRM
models. By this method, all included items serve as
anchors to determine DIF of the excluded item. To adjust
for the multiplicity of DIF assessments, LR χ2 values were
individually assessed for signiﬁcance at the Bonferroni-
adjusted α level. The Bonferroni adjustment was taken to
account for the multiplicity of hypothesis tests for DIF.
Similarly, DIF for the TRM was also assessed by
applying the methods above. In the case of the TRM,
models 3 and 6 with the random effects for testlets
ζit(j) were introduced to account for testlet effects, and
tests of γj and δj were performed. Model 6 represents
the TRM for DIF
PrðuijZkjθÞ¼
exp ðαjkþβjθþζitðjÞ þγjxþδjθixÞ
1þexp ðαjkþβjθþζitðjÞþγjxþδjθixÞ
ð6Þ
Similarly to the DIF assessments for the item-level
models, TRMs (ie, models 3 and 6) were comparedTable II. Demographic and baseline characteristics.
Characteristic
Total IBS-QOL score
Total IBS-QOL score by sex
Female
Male
Baseline IBS Symptom Severity Scale score
Baseline worst abdominal pain intensity (7-day mean, 0-1
Baseline stool consistency rating (7-day mean, Bristol Sto
Baseline No. of daily bowel movements (7-day mean)
IBS-QOL ¼ Irritable Bowel Syndrome Quality of Life.
May 2014across sexes. Further, submodels in which testlets were
removed, in turn, were also ﬁt to determine potential
differential testlet functioning and DIF within the TRM.
As was done for the GRM models above, all TRM
functioning comparisons used a Bonferroni adjustment.
Associations between Models and
Traditional Metrics
Finally, in an attempt to relate the estimation of the
latent trait θ to traditional measures of IBS-d severity,
factor scores from the CGRM, UGRM, and TRMs were
compared with the IBS Symptom Severity Scale (IBS-
SSS)18 and the IBS-QOL total scores via Spearman
correlation coefﬁcients. The IBS-SSS scores range from
0 to 500, with higher scores indicating worse symptoms,
and the IBS-QOL questionnaire scores range from 0 to
100, with higher scores representing better perceived
QOL. Estimated θ values were all on the z-score metric,
with higher values indicating worse perceived QOL.
One can further evaluate the CGRM, UGRM, and
TRM models by viewing the model ﬁt results from a
factor-analytic approach where the GRM or TRM
slopes are rescaled to be comparable to traditional
factor analysis loadings (λj).
17,19 That is:
λj ¼
αj=1:702ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1þðαj=1:702Þ2
q ð7Þ
where the factor 1.702 transforms the slopes to the
normal ogive metric. Further, as a comparison of
model estimation, factor scores and information func-
tions for θ were computed for the CGRM, UGRM,
and TRMs.No. of Patients Mean (SD)
753 53.0 (21.13)
526 51.3 (21.18)
227 57.2 (20.47)
614 342.6 (64.38)
0 rating) 753 5.89 (1.633)
ol Scale) 753 6.22 (0.426)
753 4.81 (3.274)
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Clinical TherapeuticsAll models were ﬁtted with the MIRT package, version
1.1, via R, version 3.02, using the Metropolis-Hastings-
Robins-Monro (MH-RM) ﬁtting algorithm.19,20 TheTable III. Item response frequencies.
Item*
Distribution of
1 2
1 79 (10.5) 175 (23.2)
2 86 (11.4) 163 (21.7)
3 20 (2.7) 85 (11.3)
4 193 (25.6) 226 (30.0)
5 65 (8.6) 137 (18.2)
6 183 (24.3) 188 (25.0)
7 65 (8.6) 160 (21.2)
8 128 (17.0) 183 (24.3)
9 201 (26.7) 212 (28.2)
10 225 (29.9) 228 (30.3)
11 65 (8.6) 105 (14.0)
12 287 (38.2) 178 (23.7)
13 174 (23.1) 207 (27.5)
14 221 (29.4) 231 (30.7)
15 28 (3.7) 121 (16.1)
16 101 (13.4) 213 (28.3)
17 246 (32.7) 152 (20.2)
18 98 (13.0) 183 (24.3)
19 105 (13.9) 162 (21.5)
20 269 (35.8) 174 (23.1)
21 273 (36.4) 176 (23.4)
22 188 (25.1) 232 (31.0)
23 37 (4.9) 107 (14.2)
24 260 (34.6) 183 (24.4)
25 110 (14.6) 207 (27.5)
26 176 (23.4) 186 (24.7)
27 43 (5.7) 134 (17.8)
28 112 (14.9) 141 (18.8)
29 17 (2.3) 113 (15.0)
30 128 (17.0) 165 (21.9)
31 52 (6.9) 179 (23.8)
32 547 (72.8) 95 (12.6)
33 349 (46.4) 197 (26.2)
34 243 (32.3) 211 (28.0)
*Items 1, 2, 4, 8 through 10, 12, 13, 16, 25 through 29, and 34
moderately; 4, quite a bit; and 5, extremely. Items 3, 5 throug
following response scale: 1, not at all; 2, slightly; 3, moderatel
668MH-RM algorithm was used instead of the usual
expectation-maximization algorithm because the MH-
RM has been found to work more efﬁciently for modelsItem Responses, No. (%)
3 4 5
207 (27.5) 200 (26.6) 92 (12.2)
177 (23.5) 194 (25.8) 132 (17.6)
148 (19.7) 256 (34.0) 244 (32.4)
176 (23.4) 105 (13.9) 53 (7.0)
156 (20.7) 209 (27.8) 185 (24.6)
157 (20.9) 142 (18.9) 82 (10.9)
171 (22.7) 186 (24.7) 171 (22.7)
168 (22.3) 158 (21.0) 116 (15.4)
166 (22.1) 117 (15.6) 56 (7.4)
136 (18.1) 107 (14.2) 56 (7.4)
178 (23.7) 223 (29.7) 181 (24.1)
145 (19.3) 91 (12.1) 51 (6.8)
155 (20.6) 126 (16.7) 91 (12.1)
118 (15.7) 119 (15.8) 63 (8.4)
162 (21.5) 213 (28.3) 228 (30.3)
187 (24.9) 174 (23.1) 77 (10.2)
116 (15.4) 129 (17.2) 109 (14.5)
181 (24.1) 174 (23.1) 116 (15.4)
187 (24.8) 156 (20.7) 143 (19.0)
129 (17.2) 102 (13.6) 78 (10.4)
138 (18.4) 99 (13.2) 65 (8.7)
155 (20.7) 115 (15.4) 59 (7.9)
125 (16.6) 206 (27.4) 276 (36.8)
138 (18.4) 102 (13.6) 68 (9.1)
167 (22.2) 161 (21.4) 107 (14.2)
154 (20.5) 154 (20.5) 82 (10.9)
169 (22.5) 195 (25.9) 211 (28.1)
160 (21.3) 174 (23.1) 165 (21.9)
108 (14.4) 221 (29.4) 293 (39.0)
143 (19.0) 178 (23.7) 138 (18.4)
152 (20.2) 176 (23.4) 193 (25.7)
59 (7.9) 36 (4.8) 14 (1.9)
105 (14.0) 58 (7.7) 43 (5.7)
126 (16.7) 107 (14.2) 66 (8.8)
use the following response scale: 1, not at all; 2, slightly; 3,
h 7, 11, 14, 15, 17 through 24, and 30 through 33 use the
y; 4, quite a bit; 5, a great deal.
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technical details of MH-RM are beyond the current
article; however, the algorithm basically works by
estimating starting values via a stochastic process—a
Metropolis-Hastings sampler—and then using the values
in the multivariate integrations necessary to solve the
likelihood equation via the Robins-Monro root ﬁnding
algorithm. Analysis between the IBS-SSS and IBS-QOL
scores and model-estimated latent trait values were
completed using the R package, “psych” version 1.3.12.
RESULTS
Table II lists the summary statistics for the patients.
Males made up approximately 30% of the set and had
a slightly higher IBS-QOL total score, on average
indicating higher perceived QOL. Patients’ daily
means at baseline indicated moderately high values
for IBS-SSS and pain and Bristol Stool Scale ratings.
Of note, the current patients represent a set of patients
with IBS-d because IBS-SSS scores4300 are generally
thought to indicate severe disease.18 Table III presents
the frequency distributions of the item responses.
Most items had balanced distribution of responses,
with some exceptions. Notably, 470% of patients
responded to item 32, “I fear that I won’t be able to
have a bowel movement,” with “Not at all.”
IRT and TRT Models
Model comparison statistics for the CGRM,
UGRM, and TRM models are given in Table IV.
The UGRM had a better ﬁt to the data than the
CGRM (χ234 ¼ 1189.5, P o 0.0001), indicating that
individual items differ with respect to discriminating
between latent trait levels. Tables V and VI give the
model estimates for the CGRM and UGRM ﬁts,
respectively. The CGRM location estimates hadTable IV. Comparisons of the CGRM, UGRM, and TRM
Model With Worse Fit Model With Better Fit
CGRM (model 1) UGRM (model 2)
TRM (model 3)
UGRM (model 2) TRM (model 3)
CGRM ¼ constrained graded response model; LR ¼ likelih
unconstrained graded response model.
May 2014mostly good coverage of the θ continuum (ie, on the
interval 4,4), with only a few items tending toward
the severe (eg, items 3 and 5) or the nonsevere (eg,
item 32) ends. Generally, the UGRM location
estimates covered the θ continuum well also, with a
handful of items (12, 20, 21, 32, and 33) tending to be
lacking in coverage of positive θ values (ie, worse
QOL). Conversely, only items 5 and 23 tended to
have relatively poor coverage on negative θ values.
In evaluating the differences in discrimination
between the CGRM and UGRM, inspection of
Table VI reveals that all but item 5 (β ¼ 0.99, SE ¼
0.08) have slopes signiﬁcantly higher than 1.0—the
value for β in the CGRM. Item 32, an item likely more
relevant to IBS with constipation, is the only item with
discrimination signiﬁcantly o1.0 (β ¼ 0.54, SE ¼
0.09). Furthermore, there is evidence that items
themselves have signiﬁcantly different discrimination
levels (eg, β ¼ 2.98, SE ¼ 0.15, for item 10 compared
with β ¼ 1.75, SE ¼ 0.09, for item 34).
The TRM revealed an improved ﬁt to the data than
over the UGRM (χ22 ¼ 782.7, P o 0.0001). The
improved ﬁt indicates that allowing for the covariance
among the testlet items improves model estimation.
Table VII gives the parameter estimates from the
TRM. Generally, the parameter estimates for the
TRM were similar to those for the UGRM.
Item factor loadings (λj) for the ﬁtted GRM or
TRM slopes21 are given in Table VIII. From this
framework, the sum of squared loadings—a measure
of variance in each general factor—for the UGRM
and TRM are approximately equal (16.97 vs 16.80),
and both are higher than the CGRM (8.73).
As a comparison of model estimation, factor scores
and information functions for θ were computed for the
CGRM, UGRM, and TRMs. Figure 1 displays the.
LR χ2 Δdf P
1189.549 34 o0.0001
1972.214 36 o0.0001
782.665 2 o0.0001
ood ratio; TRM ¼ testlet response model; UGRM ¼
669
Table V. CGRM (model 1) estimates.
Item (j) Slope β (SE)
Intercepts
α4,5 (SE) α3,4 (SE) α2,3 (SE) α1,2 (SE)
1 1 2.92 (0.14) 0.98 (0.10) 0.64 (0.09) 2.75 (0.13)
2 1 2.72 (0.13) 0.99 (0.10) 0.34 (0.09) 2.08 (0.12)
3 1 4.56 (0.24) 2.48 (0.12) 0.96 (0.10) 1.07 (0.10)
4 1 1.52 (0.10) 0.28 (0.09) 1.84 (0.11) 3.51 (0.16)
5 1 3.05 (0.15) 1.38 (0.10) 0.16 (0.09) 1.51 (0.11)
6 1 1.70 (0.10) 0.09 (0.09) 1.24 (0.10) 2.98 (0.14)
7 1 3.24 (0.14) 1.23 (0.10) 0.18 (0.09) 1.80 (0.11)
8 1 2.22 (0.11) 0.56 (0.09) 0.76 (0.10) 2.33 (0.12)
9 1 1.50 (0.10) 0.22 (0.09) 1.68 (0.11) 3.48 (0.16)
10 1 1.31 (0.10) 0.56 (0.09) 1.84 (0.11) 3.55 (0.16)
11 1 3.14 (0.15) 1.70 (0.11) 0.19 (0.09) 1.61 (0.11)
12 1 0.72 (0.09) 0.62 (0.09) 1.96 (0.11) 3.48 (0.16)
13 1 1.77 (0.11) 0.03 (0.09) 1.24 (0.10) 2.73 (0.13)
14 1 1.32 (0.10) 0.53 (0.09) 1.61 (0.10) 3.31 (0.15)
15 1 4.21 (0.20) 1.94 (0.11) 0.46 (0.09) 1.22 (0.10)
16 1 2.61 (0.12) 0.51 (0.09) 1.00 (0.10) 3.06 (0.14)
17 1 1.08 (0.10) 0.10 (0.09) 1.05 (0.10) 2.45 (0.12)
18 1 2.66 (0.12) 0.74 (0.09) 0.72 (0.09) 2.48 (0.12)
19 1 2.51 (0.12) 0.83 (0.09) 0.63 (0.09) 2.07 (0.11)
20 1 0.85 (0.10) 0.46 (0.09) 1.58 (0.10) 2.91 (0.14)
21 1 0.85 (0.10) 0.50 (0.09) 1.76 (0.11) 3.24 (0.15)
22 1 1.59 (0.10) 0.30 (0.09) 1.65 (0.10) 3.35 (0.15)
23 1 3.78 (0.18) 1.93 (0.11) 0.77 (0.10) 0.77 (0.10)
24 1 0.96 (0.10) 0.46 (0.09) 1.71 (0.11) 3.21 (0.15)
25 1 2.47 (0.12) 0.52 (0.09) 0.82 (0.10) 2.53 (0.12)
26 1 1.71 (0.11) 0.14 (0.09) 1.11 (0.10) 2.90 (0.14)
27 1 3.73 (0.17) 1.68 (0.10) 0.22 (0.09) 1.38 (0.10)
28 1 2.44 (0.12) 0.95 (0.10) 0.34 (0.09) 1.85 (0.11)
29 1 4.78 (0.26) 2.15 (0.11) 1.03 (0.10) 0.70 (0.09)
30 1 2.29 (0.11) 0.66 (0.09) 0.51 (0.09) 2.20 (0.11)
31 1 3.49 (0.16) 1.19 (0.10) 0.06 (0.09) 1.56 (0.10)
32 1 1.34 (0.10) 2.23 (0.12) 3.26 (0.16) 4.79 (0.28)
33 1 0.26 (0.09) 1.32 (0.10) 2.56 (0.12) 3.80 (0.17)
34 1 1.11 (0.10) 0.52 (0.09) 1.64 (0.10) 3.18 (0.15)
CGRM ¼ constrained graded response model.
Clinical Therapeuticsdensities for factor scores (ie, latent trait estimates)
generated by each model. Visual differences can be
seen between the CGRM and the other 2 models,
with the UGRM and TRM having almost identical
estimation. Figure 2 shows the information functions of670the items under each of models 1 through 3.
Information, either at the item or instrument level, is
proportional to the reciprocal of variance and so, as a
measure of precision, can be thought of as the IRT
equivalent of reliability in the CTT.21Volume 36 Number 5
Table VI. UGRM (model 2) estimates.
Item (j) Slope βj (SE)
Intercepts
α4,5 (SE) α3,4 (SE) α2,3 (SE) α1,2 (SE)
1 1.94 (0.11) 3.26 (0.17) 1.12 (0.11) 0.68 (0.10) 3.03 (0.15)
2 1.17 (0.08) 2.52 (0.13) 0.92 (0.09) 0.30 (0.08) 1.89 (0.11)
3 1.69 (0.11) 4.75 (0.27) 2.60 (0.14) 1.03 (0.10) 1.09 (0.10)
4 1.55 (0.09) 1.54 (0.10) 0.26 (0.09) 1.82 (0.11) 3.50 (0.18)
5 0.99 (0.08) 2.73 (0.14) 1.22 (0.09) 0.14 (0.08) 1.33 (0.10)
6 2.48 (0.13) 2.21 (0.14) 0.16 (0.10) 1.57 (0.12) 3.79 (0.19)
7 2.29 (0.14) 3.96 (0.20) 1.54 (0.12) 0.19 (0.10) 2.15 (0.13)
8 1.28 (0.08) 2.09 (0.12) 0.53 (0.09) 0.70 (0.09) 2.17 (0.12)
9 2.20 (0.11) 1.81 (0.12) 0.24 (0.09) 1.970 (0.13) 4.13 (0.21)
10 2.98 (0.15) 1.91 (0.13) 0.77 (0.11) 2.62 (0.16) 5.13 (0.27)
11 1.25 (0.08) 2.95 (0.15) 1.59 (0.10) 0.19 (0.08) 1.48 (0.10)
12 1.41 (0.09) 0.72 (0.09) 0.58 (0.09) 1.88 (0.11) 3.36 (0.18)
13 1.84 (0.10) 1.94 (0.11) 0.06 (0.09) 1.31 (0.11) 2.92 (0.15)
14 1.97 (0.09) 1.50 (0.11) 0.58 (0.10) 1.78 (0.12) 3.69 (0.18)
15 1.73 (0.09) 4.43 (0.23) 2.06 (0.12) 0.51 (0.09) 1.25 (0.10)
16 2.09 (0.11) 3.04 (0.15) 0.61 (0.10) 1.14 (0.11) 3.52 (0.18)
17 1.54 (0.09) 1.10 (0.09) 0.08 (0.09) 1.03 (0.10) 2.43 (0.14)
18 2.34 (0.10) 3.30 (0.17) 0.95 (0.11) 0.86 (0.10) 3.02 (0.16)
19 1.67 (0.09) 2.61 (0.13) 0.88 (0.09) 0.63 (0.09) 2.12 (0.13)
20 1.30 (0.08) 0.82 (0.09) 0.42 (0.09) 1.47 (0.10) 2.73 (0.14)
21 1.68 (0.10) 0.90 (0.09) 0.50 (0.09) 1.81 (0.12) 3.34 (0.17)
22 1.67 (0.09) 1.66 (0.11) 0.28 (0.09) 1.67 (0.11) 3.44 (0.18)
23 1.13 (0.08) 3.48 (0.18) 1.76 (0.11) 0.70 (0.09) 0.69 (0.08)
24 2.00 (0.11) 1.09 (0.10) 0.50 (0.10) 1.90 (0.12) 3.61 (0.19)
25 1.77 (0.10) 2.64 (0.14) 0.58 (0.09) 0.84 (0.10) 2.66 (0.14)
26 1.62 (0.09) 1.76 (0.11) 0.16 (0.09) 1.11 (0.10) 2.93 (0.15)
27 1.87 (0.08) 4.08 (0.21) 1.87 (0.12) 0.27 (0.10) 1.46 (0.11)
28 1.78 (0.09) 2.61 (0.14) 1.03 (0.10) 0.34 (0.09) 1.93 (0.12)
29 1.86 (0.10) 5.19 (0.29) 2.36 (0.13) 1.15 (0.10) 0.72 (0.10)
30 2.60 (0.12) 3.05 (0.16) 0.93 (0.11) 0.64 (0.11) 2.84 (0.16)
31 1.88 (0.10) 3.82 (0.19) 1.33 (0.11) 0.04 (0.09) 1.67 (0.11)
32a 0.54 (0.09) 1.02 (0.09) 1.83 (0.11) 2.73 (0.15) 4.09 (0.27)
33 1.84 (0.10) 0.30 (0.09) 1.41 (0.11) 2.75 (0.15) 4.08 (0.21)
34 1.75 (0.09) 1.20 (0.10) 0.52 (0.09) 1.71 (0.11) 3.34 (0.17)
UGRM ¼ unconstrained graded response model.
aSlope is less than constrained model slope.
D.A. Andrae et al.Differential Functioning
The reduced item set was subjected to DIF analysis
on sex. Table IX gives the DIF results. Seventeen itemsMay 2014were ﬂagged for possible DIF between males and
females for the CGRM, and 9 items were likewise
ﬂagged for the UGRM. Figure 3 through B671
Table VII. TRM (model 3) estimates.
Item (j)
Slopes Intercepts
βj (SE) ζ1 (SE) ζ2 (SE) α4,5 (SE) α3,4 (SE) α2,3 (SE) α1,2 (SE)
1 1.93 (0.10) 3.35 (0.16) 1.21 (0.10) 0.61 (0.09) 2.97 (0.15)
2 1.15 (0.07) 2.57 (0.13) 0.97 (0.09) 0.25 (0.08) 1.85 (0.11)
3 1.67 (0.10) 4.83 (0.26) 2.67 (0.14) 1.10 (0.09) 1.02 (0.09)
4 1.54 (0.07) 1.61 (0.10) 0.20 (0.08) 1.76 (0.11) 3.44 (0.17)
5* 0.97 (0.07) 2.77 (0.14) 1.26 (0.09) 0.18 (0.08) 1.28 (0.09)
6 2.49 (0.13) 2.34 (0.13) 0.27 (0.09) 1.48 (0.11) 3.73 (0.19)
7 2.29 (0.12) 4.08 (0.19) 1.65 (0.11) 0.09 (0.09) 2.07 (0.12)
8 1.28 (0.08) 2.15 (0.11) 0.58 (0.08) 0.65 (0.08) 2.13 (0.12)
9 2.22 (0.08) 1.92 (0.12) 0.15 (0.09) 1.90 (0.12) 4.09 (0.20)
10 2.97 (0.15) 2.06 (0.13) 0.64 (0.11) 2.52 (0.15) 5.04 (0.26)
11 1.93 (0.25) 1.93 (0.25) 4.57 (0.25) 2.51 (0.15) 0.38 (0.07) 2.15 (0.12)
12 2.71 (0.37) 2.71 (0.37) 1.48 (0.19) 1.13 (0.16) 3.77 (0.18) 6.56 (0.31)
13 1.83 (0.09) 2.02 (0.12) 0.14 (0.09) 1.24 (0.10) 2.86 (0.15)
14 1.98 (0.10) 1.60 (0.11) 0.50 (0.09) 1.72 (0.11) 3.64 (0.18)
15 1.70 (0.09) 4.49 (0.23) 2.12 (0.12) 0.58 (0.09) 1.18 (0.09)
16 2.07 (0.09) 3.12 (0.15) 0.70 (0.09) 1.05 (0.10) 3.43 (0.17)
17 1.53 (0.07) 1.17 (0.09) 0.02 (0.08) 0.97 (0.09) 2.37 (0.12)
18 2.33 (0.10) 3.42 (0.17) 1.06 (0.10) 0.77 (0.10) 2.94 (0.15)
19 1.63 (0.09) 2.66 (0.13) 0.94 (0.09) 0.56 (0.09) 2.04 (0.12)
20 2.24 (0.30) 2.24 (0.3) 1.51 (0.13) 0.74 (0.18) 2.64 (0.23) 4.78 (0.29)
21 1.65 (0.08) 0.97 (0.09) 0.43 (0.08) 1.74 (0.11) 3.27 (0.17)
22 1.64 (0.08) 1.72 (0.11) 0.21 (0.08) 1.60 (0.10) 3.36 (0.17)
23 1.91 (0.26) 1.91 (0.26) 5.47 (0.30) 2.84 (0.15) 1.18 (0.10) 1.01 (0.09)
24 1.97 (0.10) 1.17 (0.10) 0.42 (0.09) 1.82 (0.12) 3.52 (0.18)
25 1.74 (0.08) 2.71 (0.13) 0.65 (0.09) 0.77 (0.09) 2.59 (0.13)
26 1.60 (0.07) 1.83 (0.11) 0.23 (0.09) 1.04 (0.09) 2.86 (0.14)
27 1.83 (0.09) 4.14 (0.20) 1.93 (0.11) 0.34 (0.09) 1.38 (0.10)
28 2.28 (0.21) 2.28 (0.21) 4.00 (0.09) 1.67 (0.05) 0.35 (0.07) 2.72 (0.14)
29 1.83 (0.11) 5.25 (0.29) 2.43 (0.13) 1.23 (0.10) 0.64 (0.09)
30 2.57 (0.13) 3.16 (0.15) 1.04 (0.10) 0.53 (0.10) 2.74 (0.15)
31 1.86 (0.10) 3.90 (0.19) 1.41 (0.10) 0.04 (0.09) 1.60 (0.11)
32† 0.53 (0.09) -0.99 (0.08) 1.80 (0.11) 2.71 (0.15) 4.07 (0.27)
33 1.82 (0.10) 0.38 (0.09) 1.33 (0.10) 2.68 (0.14) 4.00 (0.21)
34 1.75 (0.08) 1.28 (0.10) 0.45 (0.09) 1.64 (0.10 3.28 (0.16)
Variances 1.00 0.98 (0.07) 1.29 (0.03)
TRM ¼ testlet response model.
*Slope is equal to constrained model slope.
†Slope is less than constrained model slope.
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Table VIII. Comparison of factor loadings.
Item
Factor Loadings (λj) for θ
CGRM UGRM TRM
1 0.507 0.751 0.751
2 0.507 0.565 0.561
3 0.507 0.705 0.701
4 0.507 0.673 0.670
5 0.507 0.502 0.495
6 0.507 0.825 0.826
7 0.507 0.803 0.803
8 0.507 0.601 0.600
9 0.507 0.791 0.793
10 0.507 0.868 0.868
11 0.507 0.591 0.600
12 0.507 0.639 0.646
13 0.507 0.735 0.733
14 0.507 0.757 0.758
15 0.507 0.713 0.707
16 0.507 0.776 0.773
17 0.507 0.671 0.667
18 0.507 0.808 0.808
19 0.507 0.701 0.692
20 0.507 0.607 0.623
21 0.507 0.702 0.697
22 0.507 0.700 0.693
23 0.507 0.551 0.598
24 0.507 0.762 0.757
25 0.507 0.720 0.716
26 0.507 0.689 0.685
27 0.507 0.740 0.733
28 0.507 0.722 0.625
29 0.507 0.737 0.732
30 0.507 0.837 0.833
31 0.507 0.741 0.738
32 0.507 0.304 0.299
33 0.507 0.734 0.730
34 0.507 0.718 0.716
Sums of
squared
loadings
8.725 16.965 16.799
CGRM ¼ constrained graded response model; LR ¼
likelihood ratio; TRM ¼ testlet response model;
UGRM ¼ unconstrained graded response model.
D.A. Andrae et al.
May 2014also graphically represent the effect of patient sex
on estimation of the latent trait for all 3 models
explored.
Associations Between Measures
To determine how well the latent variable estima-
tion of the CGRM, UGRM, and TRMs relate back to
traditional, true-score theory, outcome measures,
bivariate Spearman correlation coefﬁcients were cal-
culated between each model estimate of θ and the IBS-
SSS and 34-item IBS-QOL score, both of which have
been used previously to measure IBS disease states.6,18
Of note, for the IBS-SSS, a higher score is indicative of
more severe symptoms, higher IBS-QOL total scores
are indicative of better QOL, and higher scores on the
latent estimate scales are indicative of worse QOL.
Figure 6 illustrates the associations among the
different scales. Interestingly, the IBS-QOL question-
naire correlates extremely with the different model-
based estimates of θ. These results suggest that the
IBS-QOL is a good surrogate for the latent variable,
perceived QOL in patients with IBS-d. Furthermore,
the strength of the correlations indicates that the
associations are linear, thereby suggesting that the
IBS-QOL questionnaire is a good measure for patients
over a wide range of health-related QOL status. The
results are supported by a smaller but still strong
correlation with the IBS-SSS for the IBS-QOL ques-
tionnaire and the model estimates.
DISCUSSION
Three IRT models were ﬁt to baseline data from a
Phase II intervention trial, and increasing complexity
of the models generally improved ﬁt. These results are
not unexpected because most data sets reveal increas-
ingly better ﬁt with more complicated models. It is
also not surprising that freely estimating slopes of
items improves model ﬁt. The UGRM model ﬁt here
actually closely resembles the previous factor analyses
that have been conducted in that the items are allowed
to have different contributions to the estimation of the
latent trait/general factor (ie, perceived QOL [θ]).6,9
Unidimensional IRT models assume that there is a
single underlying trait for estimation of θ, and they
further assume local independence of items. Our TRM
model assessed whether there were dependencies
between 2 sets of items that related, conceptually, to673
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Figure 1. Comparison of estimated latent trait values (θ) for the constrained graded response model
(CGRM), the unconstrained GRM (UGRM), and the testlet response model (TRM).
Clinical Therapeuticseating and sexual habits in relation to patients’ IBS-d.
Our results indicate that although there are numeric
differences between the TRM and UGRM ﬁts, esti-
mation of perceived QOL is virtually the same
between these 2 approaches. Because IRT and TRT
models estimate latent traits on a continuum instead
of as a single true score, the information can vary over40
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20I
(θ
)
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Figure 2. Comparison of information functions, I(θ), fo
the unconstrained GRM (UGRM), and the test
determined by the area under each informatio
674the values of θ. A useful metric for determining
information is the area under the information
curve, which is presented in the legend for Figure 2.
An area under the information curve gives a single
metric of model precision over the range of θ, with
higher values generally indicating that θ is measured
more accurately. Visual inspection of the information0 2
CGRM ( 68.39 )
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Table IX. Items and testlets that revealed possible differential functioning due to sex.
Item or Testlet Excluded
CGRM UGRM
LR χ2 Pr(χ2)a LR χ2 Pr(χ2)a
1. I feel helpless because of my bowel problems. 60.89 o0.001
2. I am embarrassed by the smell caused by my bowel problems. 128.37 o0.001 14.11 0.0293
4. I feel vulnerable to other illnesses because of my bowel problems. 55.38 o0.0001
5. I feel fat because of my bowel problems. 91.42 o0.0001 36.89 o0.0001
6. I feel like I’m losing control of my life because of my bowel problems. 35.97 o0.0001
11. I have to watch the amount of food I eat because of my bowel
problems.
35.63 o0.0001
13. I feel angry that I have bowel problems. 26.58 o0.0001
14. I feel like I irritate others because of my bowel problems. 19.72 0.0018
15. I worry that my bowel problems will get worse. 35.67 o0.0001
16. I feel irritable because of my bowel problems. 17.26 0.0061
17. I worry that people think I exaggerate my bowel problems. 27.39 o0.0001
19. I have to avoid stressful situations because of my bowel problems. 42.54 o0.0001
21. My bowel problems limit what I can wear. 81.17 o0.0001 28.80 o0.0001
22. I have to avoid strenuous activity because of my bowel problems. 67.40 o0.0001
23. I have to watch the kind of food I eat because of my bowel problems. 29.31 o0.0001
25. I feel sluggish because of my bowel problems. 127.57 o0.0001
26. I feel unclean because of my bowel problems. 40.61 o0.0001
27. Long trips are difﬁcult for me because of my bowel problems. 47.36 o0.0001
28. I feel frustrated that I cannot eat when I want because of my bowel
problems.
47.48 o0.0001
29. It is important to be near a toile t because of my bowel problems. 16.98 0.0070
31. I worry about losing control of my bowels. 53.08 o0.0001
33. My bowel problems are affecting my closest relationships. 39.02 o0.0001
34. I feel that no one understands my bowel problems. 16.49 0.0089
I. Items 11, 23, and 28 o1.00 40.9999
II. Items 12 and 20 o1.00 40.9999
CGRM ¼ constrained graded response model; LR ¼ likelihood ratio; Pr ¼ probability; UGRM ¼ unconstrained graded
response model.
aDisplayed P values are adjusted using the Bonferroni procedure.
D.A. Andrae et al.functions reveals that both the UGRM and TRM hold
more information than the CGRM. The total
information values for the UGRM and TRM (149.97
and 149.40, respectively) are higher than that for the
CGRM (68.39). Interestingly, although the UGRM
and TRM information levels are virtually equal, their
information functions differ. The UGRM has a wider
and ﬂatter information function, whereas the TRM
information function has a much more distinctive
peak. One interpretation of this pattern is that theMay 2014TRM helps discriminate ﬁnely around the mean at the
expense of discrimination away from the mean,
whereas the UGRM has a better overall coverage of
the θ continuum. The only notable difference in
information estimation was that the TRM model
appears be superior to the UGRM around the
sample mean; however, the TRM did not maintain
this higher level of discrimination over the entire θ
continuum. One interpretation of these results is that
the TRM may provide added discrimination between675
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Figure 3. Effect of items with possible differential item functioning (DIF) due to sex on constrained graded
response model estimates of the latent trait (θ).
Clinical TherapeuticsIBS-d and other IBS subtypes in a mixed analysis set—
an interesting future potential research area.
Likewise, potential DIF associated with patient sex
revealed numeric differences on certain items but did not
seem to affect overall estimates of perceived QOL—as
measured by θ—for any of the GRM or TRM ap-
proaches. With regard to the UGRM, despite 9 items
revealing potential DIF at the Bonferroni-adjusted
α ¼ .05 level, the effect on the overall density of the0.4
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Figure 4. Effect of items with possible differential item fu
response model estimates of the latent trait (θ
676latent trait is negligible (Figure 4), as evidenced by the
overlap in densities between estimates from the full item
set vs the set of 25 items not ﬂagged for potential DIF.
Neither of the 2 testlets exhibited potential DIF by the
LR criterion. There is of interest when exploring the
potential DIF of the IBS-QOL items among racial
groups. For the current data, however, nonwhite pa-
tients only totaled 107, a number deemed currently too
small to evaluate DIF. Evaluating potential DIF in racialWith DIF Items
Without DIF Items
0 2
θ
nctioning (DIF) due to sex on unconstrained graded
).
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Figure 6. Scatterplot matrix of the IBS-SSS, 34-item Irritable Bowel Syndrome Quality of Life (IBS-QOL) total
score with the latent trait (θ) estimates from the constrained graded response model (CGRM), the
unconstrained GRM (UGRM), and the testlet response model (TRM) vs the IBS-QOL total score for
32 items. The lower triangle represents scatterplots with regression lines overlaid, the diagonal
depicts the data densities of the scores, and the upper triangle displays the Spearman correlation
coefficients among the scores.
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may be possible when currently enrolling large-scale
Phase III studies are completed.
Despite the observed gains in model ﬁt with TRM
models, comparison of the estimated perceived QOL
from the CGRM, UGRM, and TRM approaches
were not only found to be consistent with the IBS-
SSS but also correlated at an extremely high level
with the original scoring of the IBS-QOL on the 34-
item set (|r| ≥ 0.99 for all parwise comparisons of IBS-
QOL and latent trait estimates). These results under-
score the consistency in the items for the data set
analyzed in terms of measuring latent perceived QOL
related to IBS-d. Interestingly, despite the fact that the
IBS-SSS is more of a symptom inventory and the IBS-
QOL questionnaire is intended to measure perceived
QOL, the Spearman correlation of 0.47 indicates that
symptom severity and perceived QOL are related at a
moderate to high level.22
Our results support previous IBS-QOL validations
in many ways. Despite increasing item ﬁts with
complexity of the models, one can still conclude that
the IBS-QOL questionnaire is measuring a unidimen-
sional construct. When viewing the model slope
results from a factor analytic perspective, the results
indicate not only that free estimation of item slopes
help measurement of perceived QOL in patients with
IBS-d but also that the models support the idea of
approximate unidimensionality of θ because the
model loadings are all positive and high by usual
evaluation standards for factor analysis. Furthermore,
comparison among the IBS-SSS, IBS-QOL total score,
and the factor scores from CGRM, UGRM, and TRM
models yielded strikingly consistent results, which
further buttressed the position that the IBS-QOL
questionnaire is measuring perceived QOL in IBS-d
patients and doing so well (Figure 5).
CONCLUSION
Irritable bowel syndrome is a condition in which
severity is measured by patient reports of their physical
and psychological symptoms. The IBS-QOL question-
naire is a psychometrically sound instrument for
measuring perceived QOL in both male and female
patients with IBS-d. Although there is evidence for local
dependencies among individual items of the IBS-QOL
questionnaire, these local dependencies do not appear
to detrimentally inﬂuence perceived QOL measure-
ment, and we have established that the original scoring678is a viable surrogate for perceived QOL. Adding model
complexity within a structure that corresponded with
theory around the IBS-QOL measurement model re-
vealed superior results; however, it appears that in the
case of the IBS-QOL, the added model complexity
simply added to our understanding of the baseline
measurement properties of the instrument and did not
offer much in the way of improving the scoring of the
IBS-QOL. Rather, the original scoring of the IBS-QOL
stands up well with estimates from more complex
latent variable modeling techniques. The IBS-QOL
was developed under a needs-based conceptual model.6
This conceptual model has held up well to quantitative
scrutiny that further underscores its validity for
measuring perceived QOL.
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